ArticleBMC infectious diseases2025
Social vulnerability and the risk of respiratory virus infection in households: a case-ascertained study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Remote Recruitment to Diversify Infant Research Participation: Lessons From the Infant Vaccine Biepository.Acta paediatrica (Oslo, Norway : 1992) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
objectivesThis study examines whether the Social Vulnerability Index (SVI), a location-based composite measure of social vulnerability, is associated with the risk of SARS-CoV-2 or influenza infection within households. STUDY
designProspective cohort case-ascertained household transmission study.
methodsWe analyzed data from a case-ascertained household transmission study conducted across multiple U.S. sites (September 2021–May 2023). Household contacts of index cases with confirmed infections self-collected nasal swabs daily for ten days, tested via RT-PCR for SARS-CoV-2 or influenza. Age, sex, and vaccine receipt were self-reported, with vaccination verified. Household addresses were geocoded to 2020 census tracts and linked to the national SVI percentile. Using modified Poisson regression models with generalized estimating equations, we assessed associations between census tract-level SVI and infection risk, adjusting for age, sex, vaccine receipt, and clustering by census tract. Participants included household contacts of index cases with SARS-CoV-2 (793 households, 1,408 participants) or influenza (273 households, 512 participants).
resultsWe found that higher overall SVI was associated with increased SARS-CoV-2 infection risk (adjusted Incidence risk ratio [aIRR] 1.24; 95% CI: 1.00, 1.52). Specifically, the socioeconomic SVI domain was linked to higher infection risk (aIRR = 1.24; 95% CI: 1.02, 1.51). Other SVI domains were not statistically significant. For influenza, SVI was overall associated with greater infection, but confidence intervals crossed the null (aIRR = 1.45; 95% CI: 0.88, 2.39).
conclusionsHousehold contacts of SARS-CoV-2 index cases in high-SVI areas faced an increased risk of infection. No significant association was found for influenza, likely due to the small sample size. Increased access to SARS-CoV-2 testing, treatment, and preventive measures (e.g., masking, handwashing, isolation) may be especially important in high-SVI areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.